• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Hercules Capital Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events

    7/21/26 8:44:20 AM ET
    $HTGC
    Investment Managers
    Finance
    Get the next $HTGC alert in real time by email
    htgc-20260721
    0001280784false00012807842026-07-212026-07-210001280784htgc:CommonStockParValueZeroPointZeroZeroOnePerShareMember2026-07-212026-07-210001280784htgc:SixPointTwoFiveNotesDueTwoThousandThirtyThreeMember2026-07-212026-07-21


     
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549
     
     
    FORM 8-K
     
    CURRENT REPORT
    Pursuant to Section 13 or 15(d)
    of the Securities Exchange Act of 1934
    Date of Report (Date of earliest event reported): July 21, 2026
     
    Hercules Capital, Inc.
    (Exact name of registrant as specified in its charter)
     
     
    Maryland 814-00702 74-3113410
    (State or other jurisdiction
    of incorporation)
     
    (Commission
    File No.)
     
    (I.R.S. Employer
    Identification No.)
    1 North B Street, Suite 2000
    San Mateo, CA
     94401
    (Address of principal executive offices) (Zip Code)
    Registrant’s telephone number, including area code: (650) 289-3060
    Not Applicable
    (Former name or address, if changed since last report)  
    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
    ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    Securities registered pursuant to Section 12(b) of the Act:
    Title of each class 
    Trading
    Symbol(s)
     
    Name of each exchange
    on which registered
    Common Stock, par value $0.001 per share HTGC New York Stock Exchange
    6.25% Notes due 2033 HCXY New York Stock Exchange
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter)
    Emerging growth company   ☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐



    Item 2.02
    Results of Operations and Financial Condition

    Set forth below are preliminary estimates of Hercules Capital, Inc. (the “Company”, “we” or “our”) as of and for the quarter ended June 30, 2026, which are estimated as of July 21, 2026. The preliminary financial data included in this Current Report on Form 8-K has been prepared by, and is the responsibility of, the Company’s management. The Company’s independent registered public accounting firm has not audited, reviewed, examined, compiled, nor applied agreed-upon procedures with respect to the preliminary financial data. Accordingly, the Company’s independent registered public accounting firm does not express an opinion or any other form of assurance with respect thereto. The preliminary data is subject to completion of the Company’s financial closing and review procedures and is not a comprehensive statement of the Company’s financial results or valuations as of, or for the period ended, June 30, 2026. Actual results may differ materially from this preliminary data as a result of the completion of the Company’s financial closing and review procedures, final adjustments, valuation process and other developments that may arise between now and the time that the Company’s financial results for such period are finalized.

    As of the date hereof:

    •The preliminary estimate of our net asset value (“NAV”) per share of our common stock as of June 30, 2026 is in the range of $12.10 to $12.20, representing an increase of $0.20 to $0.30 per share, or 1.7% to 2.5%, from the NAV per share of $11.90 as of March 31, 2026.

    •The preliminary estimate of our second quarter 2026 net realized gains/(losses) is approximately $7.7 million of net realized gains.
    •The preliminary estimate of our second quarter 2026 net investment income is in the range of $0.49 to $0.51 per share of our common stock.
    •The preliminary estimate of our second quarter 2026 gross new investment commitments and fundings is approximately $0.9 billion and $0.6 billion, respectively.
    •We preliminarily estimate that our investments on non-accrual status comprised <0.5% of the total investment portfolio at cost as of June 30, 2026, representing an increase from 0.2% of the total investment portfolio at cost as of March 31, 2026.
    •The preliminary estimate of our total investments at fair value as of June 30, 2026 is approximately $4.5 to $4.6 billion.

    The information disclosed under this Item 2.02 is being “furnished” and shall not be deemed “filed” by the Company for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, and shall not be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

    Item 8.01.Other Events

    The information disclosed under Item 2.02 of this Current Report on Form 8-K is incorporated by reference into this Item 8.01.
     







    Forward-Looking Statements

    This Current Report on Form 8-K may contain “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. We may use words such as “anticipates,” “believes,” “expects,” “intends,” “will,” “should,” “may” and similar expressions to identify forward-looking statements. Forward-looking statements are not guarantees of future performance and should not be relied upon in making any investment decision. Such statements are based on currently available operating, financial and competitive information and are subject to various risks and uncertainties that could cause actual results to differ materially from our historical experience and our present expectations. While we cannot identify all such risks and uncertainties, we urge you to read the risks discussed in our Annual Report on Form 10-K and other materials that we publicly file with the Securities and Exchange Commission. Any forward-looking statements made herein are made only as of the date hereof. We assume no obligation to update any such statements in the future.






    SIGNATURES
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
     
      HERCULES CAPITAL, INC.
    July 21, 2026  
      By: /s/ Kiersten Zaza Botelho
       Kiersten Zaza Botelho
       Secretary


    Get the next $HTGC alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HTGC

    DatePrice TargetRatingAnalyst
    2/13/2026$17.50Overweight → Neutral
    Piper Sandler
    11/4/2025$19.50Neutral → Buy
    Compass Point
    12/12/2024$19.50 → $21.50Mkt Perform → Outperform
    Keefe Bruyette
    1/16/2024$17.00 → $17.50Buy → Neutral
    Compass Point
    11/21/2023$17.00Neutral
    UBS
    8/30/2023$17.50Neutral → Buy
    Compass Point
    8/4/2023$13.50 → $17.00Underperform → Mkt Perform
    Keefe Bruyette
    4/6/2023$16.00Neutral → Overweight
    Piper Sandler
    More analyst ratings

    $HTGC
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Operating Officer Follmann Christian covered exercise/tax liability with 2,798 shares, decreasing direct ownership by 2% to 144,539 units (SEC Form 4)

    4 - Hercules Capital, Inc. (0001280784) (Issuer)

    7/13/26 2:41:20 PM ET
    $HTGC
    Investment Managers
    Finance

    President Meyer Seth H covered exercise/tax liability with 6,469 shares, decreasing direct ownership by 1% to 435,605 units (SEC Form 4)

    4 - Hercules Capital, Inc. (0001280784) (Issuer)

    7/13/26 2:39:18 PM ET
    $HTGC
    Investment Managers
    Finance

    Chief Executive Officer Bluestein Scott covered exercise/tax liability with 20,393 shares, decreasing direct ownership by 0.82% to 2,475,593 units (SEC Form 4)

    4 - Hercules Capital, Inc. (0001280784) (Issuer)

    7/13/26 2:38:27 PM ET
    $HTGC
    Investment Managers
    Finance

    $HTGC
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Hercules Capital Prices Institutional Notes Offering of $325.0 Million 6.300% Notes due 2031

    Hercules Capital, Inc. (NYSE:HTGC) ("Hercules," "Hercules Capital," or the "Company"), today announced that it has priced an underwritten public offering of $325.0 million in aggregate principal amount of 6.300% notes due July 2031 (the "Notes"). The closing of the transaction is subject to customary closing conditions and the Notes are expected to be delivered and paid for on July 24, 2026. The Notes are unsecured and bear interest at a rate of 6.300% per year, payable semiannually and will mature on July 24, 2031 and may be redeemed in whole or in part at any time or from time to time at the Company’s option at par, plus a "make whole" premium, if applicable. The Company expects to us

    7/21/26 4:15:00 PM ET
    $HTGC
    $HCXY
    Investment Managers
    Finance

    Hercules Capital Announces Date for Release of Second Quarter 2026 Financial Results and Conference Call

    Hercules Capital, Inc. (NYSE:HTGC) ("Hercules," "Hercules Capital," or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its second quarter 2026 financial results conference call for Thursday, July 30, 2026, at 2:00 p.m. PT (5:00 p.m. ET). Hercules will release its financial results after market close that same day. All interested parties are invited to participate via telephone or the live webcast, which will be hosted on a webcast link located on the Investor Resources section of

    7/16/26 6:00:00 AM ET
    $HTGC
    $HCXY
    Investment Managers
    Finance

    4DMT Secures Strategic Credit Facility for up to $200 Million from Hercules Capital

    EMERYVILLE, Calif., June 29, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (NASDAQ:FDMT, 4DMT or the Company)), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced that it has entered into a strategic credit facility agreement with Hercules Capital, Inc. (NYSE:HTGC) ("Hercules") for up to $200 million. "Our strong cash, cash equivalents and marketable securities position, excluding this strategic credit facility, is expected to continue to fund our planned operations into the second half of 2028. Access to this non-dilutive capital

    6/29/26 8:00:00 AM ET
    $FDMT
    $HTGC
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Investment Managers
    Finance

    $HTGC
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Hercules Capital downgraded by Piper Sandler with a new price target

    Piper Sandler downgraded Hercules Capital from Overweight to Neutral and set a new price target of $17.50

    2/13/26 8:28:49 AM ET
    $HTGC
    Investment Managers
    Finance

    Hercules Capital upgraded by Compass Point with a new price target

    Compass Point upgraded Hercules Capital from Neutral to Buy and set a new price target of $19.50

    11/4/25 7:20:09 AM ET
    $HTGC
    Investment Managers
    Finance

    Hercules Capital upgraded by Keefe Bruyette with a new price target

    Keefe Bruyette upgraded Hercules Capital from Mkt Perform to Outperform and set a new price target of $21.50 from $19.50 previously

    12/12/24 8:09:58 AM ET
    $HTGC
    Investment Managers
    Finance

    $HTGC
    Financials

    Live finance-specific insights

    View All

    Hercules Capital Announces Date for Release of Second Quarter 2026 Financial Results and Conference Call

    Hercules Capital, Inc. (NYSE:HTGC) ("Hercules," "Hercules Capital," or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its second quarter 2026 financial results conference call for Thursday, July 30, 2026, at 2:00 p.m. PT (5:00 p.m. ET). Hercules will release its financial results after market close that same day. All interested parties are invited to participate via telephone or the live webcast, which will be hosted on a webcast link located on the Investor Resources section of

    7/16/26 6:00:00 AM ET
    $HTGC
    $HCXY
    Investment Managers
    Finance

    Hercules Capital Announces Date of 2026 Annual Meeting of Stockholders

    Hercules Capital, Inc. (NYSE:HTGC) ("Hercules," "Hercules Capital," or the "Company"), will conduct its 2026 Annual Meeting of Stockholders by virtual meeting on Thursday, June 18, 2026 at 9:00 a.m. (Eastern Time). The proxy statement for the meeting was filed on April 23, 2026 and mailed to stockholders of record as of April 9, 2026. 2026 Annual Meeting of Stockholders June 18, 2026 at 9:00 a.m. Eastern Time Virtual Meeting via Internet: http://www.virtualshareholdermeeting.com/HTGC2026 Matters to be voted on include: 1) election of an independent director, 2) an advisory vote to approve the Company's named executive officer compensation, 3) an advisory vote on the frequency of the adv

    5/7/26 6:00:00 AM ET
    $HCXY
    $HTGC
    Investment Managers
    Finance

    Hercules Capital Reports First Quarter 2026 Financial Results

    Record Q1 2026 Total New Debt and Equity Commitments of $1.81 Billion, an Increase of 77.8% Year-over-Year Q1 2026 Total Fundings of $706.4 Million, an Increase of 31.0% Year-over-Year Record Q1 2026 Total Investment Income of $141.5 Million, an Increase of 18.4% Year-over-Year Q1 2026 Net Investment Income "NII" of $88.1 Million, an Increase of 13.8% Year-over-Year Q1 2026 NII of $0.48 per Share provides 120% Coverage of the Base Cash Distribution Closed Institutional Notes Offering of $300.0 Million of 5.350% Unsecured Notes due 2029 Conservative Balance Sheet Management with Net GAAP Leverage of 113.5% and Net Regulatory Leverage of 97.8%(1) Inclusive of the Adviser Funds A

    5/5/26 4:05:00 PM ET
    $HCXY
    $HTGC
    Investment Managers
    Finance

    $HTGC
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Amendment: Chief Operating Officer Follmann Christian bought $73,400 worth of shares (5,000 units at $14.68), increasing direct ownership by 3% to 150,135 units (SEC Form 4)

    4/A - Hercules Capital, Inc. (0001280784) (Issuer)

    3/5/26 5:19:12 PM ET
    $HTGC
    Investment Managers
    Finance

    Chief Operating Officer Follmann Christian decreased direct ownership by 3% to 150,135 units (SEC Form 4)

    4 - Hercules Capital, Inc. (0001280784) (Issuer)

    3/5/26 3:53:29 PM ET
    $HTGC
    Investment Managers
    Finance

    Director Randhawa Paramjeet K bought $45,079 worth of shares (3,050 units at $14.78), increasing direct ownership by 18% to 19,560 units (SEC Form 4)

    4 - Hercules Capital, Inc. (0001280784) (Issuer)

    3/5/26 2:54:35 PM ET
    $HTGC
    Investment Managers
    Finance

    $HTGC
    SEC Filings

    View All

    SEC Form 497AD filed by Hercules Capital Inc.

    497AD - Hercules Capital, Inc. (0001280784) (Filer)

    7/21/26 4:33:58 PM ET
    $HTGC
    Investment Managers
    Finance

    SEC Form FWP filed by Hercules Capital Inc.

    FWP - Hercules Capital, Inc. (0001280784) (Subject)

    7/21/26 4:27:20 PM ET
    $HTGC
    Investment Managers
    Finance

    Hercules Capital Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events

    8-K - Hercules Capital, Inc. (0001280784) (Filer)

    7/21/26 8:44:20 AM ET
    $HTGC
    Investment Managers
    Finance

    $HTGC
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Hercules Capital Inc.

    SC 13G - Hercules Capital, Inc. (0001280784) (Subject)

    5/8/23 5:06:26 PM ET
    $HTGC
    Investment Managers
    Finance

    SEC Form SC 13G/A filed by Hercules Capital Inc. (Amendment)

    SC 13G/A - Hercules Capital, Inc. (0001280784) (Filed by)

    10/12/22 9:11:00 AM ET
    $HTGC
    Investment Managers
    Finance

    SEC Form SC 13G filed by Hercules Capital Inc.

    SC 13G - Hercules Capital, Inc. (0001280784) (Filed by)

    4/27/22 4:31:08 PM ET
    $HTGC
    Investment Managers
    Finance

    $HTGC
    Leadership Updates

    Live Leadership Updates

    View All

    Snappt Acquires Trigo to Enhance Applicant Trust Platform for Multifamily Housing, Secures $50M Growth Financing

    Strategic growth financing accelerates expansion through acquisition and supports product innovation Snappt, the leading platform for applicant trust in multifamily housing, today announced it has acquired Trigo, a company known for its breakthrough technology in verifying rental payment history. Backed by a $50 million committed facility from Hercules Capital, Inc. (NYSE:HTGC), the acquisition expands Snappt's platform and strengthens its ability to help property managers make faster, more confident leasing decisions. Together, these milestones mark a major step toward building the industry's most complete and trusted solution embedded into the application and screening process. "This

    8/5/25 12:00:00 PM ET
    $HTGC
    Investment Managers
    Finance

    Revelation Partners Expands Team with Hire of Andrew Olson, Partner, Chief Financial Officer & Chief Operating Officer

    SAUSALITO, Calif., Nov. 29, 2023 /PRNewswire/ -- Revelation Partners, a healthcare investment firm with over $1.5 billion of capital under management, announced today the addition of Andrew Olson as Partner, Chief Financial Officer and Chief Operating Officer. Mr. Olson has an extensive background in the venture capital and funds management industry. His addition to the team will enhance the firm's technical expertise, support the differentiated investment model, and strengthen the firm's ongoing foundation. As the firm's new Chief Financial Officer and Chief Operating Officer

    11/29/23 1:01:00 PM ET
    $HTGC
    $TPVG
    Investment Managers
    Finance
    Other Consumer Services
    Consumer Discretionary

    Hercules Capital Announces the Appointment of Mr. Nikos Theodosopoulos to Its Board of Directors

    Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that Nikos Theodosopoulos was appointed to serve as an independent member of its board of directors, effective September 21, 2023. Mr. Theodosopoulos is an experienced corporate executive and board director with more than 38 years in senior management roles in both the financial services and technology industries. Mr. Theodosopoulos will serve on the Company's Audit Committee. "Nikos' combined experienc

    9/25/23 6:00:00 AM ET
    $HCXY
    $HTGC
    Investment Managers
    Finance